Immune
TA-1
Thymosin Alpha-1
Scientific Overview
Thymosin alpha-1 (TA-1) is a 28βamino-acid thymic peptide. Reviews examine its activity in innate and adaptive immune-cell models and summarize a large clinical literature without this page restating outcome claims.
Mechanism focus: Laboratory work explores T-cell and dendritic-cell related signaling. It is a thymic immune peptide, distinct from thymosin beta-4 fragments such as TB-500.
Research Use Cases
- Immune-cell signaling assays
- Thymic peptide characterization
- Innate and adaptive immunity models
- Analytical confirmation of the thymosin alpha-1 sequence
Use-Case Study Notations
- Case-study notation: narrative reviews summarize thymosin alpha-1 as a thymic immune peptide.
- Case-study notation: later reviews compile human clinical-trial literature under research and medical headings.
- TB-500 is a different thymosin fragment. Sequence identity should be confirmed on the certificate of analysis.
Selected Studies (English, PubMed)
Five peer-reviewed sources indexed on PubMed. Links open the PubMed record for verification.
- Thymosin alpha-1 β PubMed 11381492
- Thymosin alpha 1: A comprehensive review of the literature β PubMed 33362999
- Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 in Human Clinical Trials β PubMed 38308608
- Aging and Thymosin Alpha-1 β PubMed 41373628
- Thymosin Ξ±-1 in cancer therapy: Immunomodulatory mechanisms, clinical applications, and translational perspectives β PubMed 42641753
Related compounds
Research Use Only. This page is educational and intended for laboratory research context. Products are not for human consumption and are not intended to diagnose, treat, cure, or prevent any disease.